CXCL1/CXCL2/CXCL3 Monoclonal Antibody (29702) | Invitrogen MA5-23920 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

CXCL1/CXCL2/CXCL3 Monoclonal Antibody (29702)

catalog :

MA5-23920

quantity :

100 ug

price :

US 414.00

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

29702

The same clone is also sold as:

R&D Systems: MAB2761

reactivity :

human

application :

western blot, flow cytometry

product information

Product Type :

Antibody

Product Name :

CXCL1/CXCL2/CXCL3 Monoclonal Antibody (29702)

Catalog # :

MA5-23920

Quantity :

100 ug

Price :

US 414.00

Clonality :

Monoclonal

Purity :

Protein A/G

Host :

Mouse

Reactivity :

Human

Applications :

Flow Cytometry: 2.5 ug per million cells, Western Blot: 1 ug/mL

Species :

Human

Clone :

29702

Isotype :

IgG1

Storage :

-20 C, Avoid Freeze/Thaw Cycles

Description :

CXCL1, CXCL2, and CXCL3, also known respectively as GRO alpha, GRO beta (MIP-2 alpha) and GRO gamma (MIP-2 beta), are members of the CXC subfamily of chemokines. Mature CXCL1/2/3 proteins bind with high affinity to the IL-8 receptor type B and are potent neutrophil attractants and activators. In vitro, the processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic activity.

Immunogen :

E. coli-derived recombinant human CXCL3 Ala35-Asn107

Format :

Lyophilized

Applications w/Dilutions :

Flow Cytometry: 2.5 ug per million cells, Western Blot: 1 ug/mL

Aliases :

C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha); chemokine (C-X-C motif) ligand 2; chemokine (C-X-C motif) ligand 3; CINC-2a; CINC-2b; CXC; CXC motif chemokine; C-X-C motif chemokine 1; C-X-C motif chemokine 2; C-X-C motif chemokine 3; C-X-C motif chemokine ligand 1; C-X-C motif chemokine ligand 2; C-X-C motif chemokine ligand 3; CXCL; CXCL1; CXCL2; CXCL3; fibroblast secretory protein; FSP; GRO; GRO a; gro beta; gro gamma; GRO a; GRO1; GRO1 oncogene (melanoma growth stimulating activity, alpha); GRO1 oncogene (melanoma growth-stimulating activity); GRO2; GRO2 oncogene; GRO3; GRO3 oncogene; GROa; GROalpha; GRO-alpha(1-73); GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73); GROB; Gro-beta; GRO-beta(5-73); GRO-beta-T; GROG; GRO-gamma; GRO-gamma(1-73); GRO-gamma(5-73); Growth-regulated alpha protein; growth-regulated protein beta; Growth-regulated protein gamma; GROa; Hematopoietic synergistic factor; HSF; Macrophage inflammatory protein 2-alpha; macrophage inflammatory protein 2-beta; melanoma growth stimulating activity, alpha; Melanoma growth stimulatory activity; melanoma growth stimulatory activity alpha; melanoma growth stimulatory activity beta; melanoma growth stimulatory activity gamma; MGSA; MGSA alpha; MGSA beta; MGSA gamma; MGSA-a; MGSA-b; MIP2; MIP2A; MIP-2a; MIP2-alpha; MIP2B; MIP-2b; MIP2-beta; NAP3; NAP-3; Neutrophil-activating protein 3; SB-251353; SCYB1; SCYB2; SCYB3